CL2017002034A1 - Nueva triterpenona c-3 con derivados de amida inversa c-17 como inhibidores de vih. - Google Patents

Nueva triterpenona c-3 con derivados de amida inversa c-17 como inhibidores de vih.

Info

Publication number
CL2017002034A1
CL2017002034A1 CL2017002034A CL2017002034A CL2017002034A1 CL 2017002034 A1 CL2017002034 A1 CL 2017002034A1 CL 2017002034 A CL2017002034 A CL 2017002034A CL 2017002034 A CL2017002034 A CL 2017002034A CL 2017002034 A1 CL2017002034 A1 CL 2017002034A1
Authority
CL
Chile
Prior art keywords
new
triterpenone
amide derivatives
hiv inhibitors
reverse amide
Prior art date
Application number
CL2017002034A
Other languages
English (en)
Inventor
Reddy Bandi Parthasaradhi
Krupadanam Gazula Levi David
Reddy Adulla Panduranga
Reddy Kasireddy Bhaskar
Subrahmanyam Lanka Vl
Reddy Kura Rathnakar
Original Assignee
Hetero Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=57153504&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2017002034(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hetero Labs Ltd filed Critical Hetero Labs Ltd
Publication of CL2017002034A1 publication Critical patent/CL2017002034A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

<p>LA INVENCIÓN SE REFIERE A UNA NUEVA TRITERPENOMA C-3 CON DERIVADOS AMIDA INVERSA C-17, COMPUESTOS RELACIONADOS Y COMPOSICIONES FARMACÉUTICAS ÚTILES PARA EL TRATAMIENTO TERAPÉUTICO DE ENFERMEDADES VIRALES Y PARTICULARMENTE ENFERMEDADES MEDIADAS POR VIH.</p>
CL2017002034A 2015-02-09 2017-08-09 Nueva triterpenona c-3 con derivados de amida inversa c-17 como inhibidores de vih. CL2017002034A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN623CH2015 2015-02-09

Publications (1)

Publication Number Publication Date
CL2017002034A1 true CL2017002034A1 (es) 2018-04-27

Family

ID=57153504

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017002034A CL2017002034A1 (es) 2015-02-09 2017-08-09 Nueva triterpenona c-3 con derivados de amida inversa c-17 como inhibidores de vih.

Country Status (22)

Country Link
US (3) US20170008921A1 (es)
EP (1) EP3256483B1 (es)
JP (1) JP2018505216A (es)
KR (1) KR20170110143A (es)
CN (1) CN107428797A (es)
AU (1) AU2016258274B2 (es)
BR (1) BR112017017109A2 (es)
CA (1) CA2975359A1 (es)
CL (1) CL2017002034A1 (es)
CO (1) CO2017008765A2 (es)
CU (1) CU24476B1 (es)
DK (1) DK3256483T3 (es)
EA (1) EA033264B1 (es)
ES (1) ES2780649T3 (es)
IL (1) IL253844A0 (es)
MA (1) MA40886B1 (es)
MX (1) MX2017010297A (es)
PE (1) PE20171433A1 (es)
PH (1) PH12017550077A1 (es)
SG (1) SG11201706189PA (es)
WO (1) WO2016178092A2 (es)
ZA (1) ZA201705253B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
US10370405B2 (en) * 2015-03-16 2019-08-06 Hetero Labs Limited C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
AR107512A1 (es) 2016-02-04 2018-05-09 VIIV HEALTHCARE UK Nº 5 LTD Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1
WO2018029604A1 (en) * 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors
WO2019150300A1 (en) 2018-02-02 2019-08-08 Glaxosmithkline Intellectual Property (No.2) Limited Crystalline forms of 4-(((3ar,5ar,5br,7ar,9s,11ar,11br,13as)-3a-((r)-2-((4-chlorobenzyl)(2-(dimethylamino)ethyl)amino)-1-hydroxyethyl)-1-isopropyl-5a,5b,8,8,11a-pentamethyl-2-oxo-3,3a,4,5,5a,5b,6,7,7a,8,9,10,11,11a,11b,12,13,13a-octadecahydro-2h-cyclopenta[a]chrysen-9-yl)oxy)-2,2-dimethyl-4-oxobutanoic acid
EP3852879A1 (en) 2018-09-21 2021-07-28 Pfizer Inc. N-substituted-dioxocyclobutenylamino-3-hydroxy-picolinamides useful as ccr6 inhibitors
CN109705189B (zh) * 2018-12-29 2020-06-05 中国医学科学院药用植物研究所 具有式i所示结构的三萜衍生物及其制备方法和应用
WO2020165742A1 (en) * 2019-02-11 2020-08-20 Hetero Labs Limited Novel triterpenone derivatives as hiv inhibitors

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58152815A (ja) 1982-03-05 1983-09-10 Tamio Nishimura 医療用抗ウイルス剤
CA2165188A1 (en) 1993-07-09 1995-01-19 Neal A. Deluca Selection and use of antiviral peptides
US5679828A (en) 1995-06-05 1997-10-21 Biotech Research Labs, Inc. Betulinic acid and dihydrobetulinic acid derivatives and uses therefor
AU7124398A (en) 1997-04-15 1998-11-11 Medichem Research, Inc. Biflavinoids and derivatives thereof as antiviral agents, alone or in combination with at least one known antiviral agent
HUP9701080A3 (en) 1997-06-23 1999-05-28 Gene Res Lab Inc New York N Pharmaceutical composition containing a compound of antiviral activity and a hydroximic acid ester derivative
US6670345B1 (en) 1997-09-30 2003-12-30 Dabur Research Foundation Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid
US6427248B1 (en) 1997-10-09 2002-08-06 David M. Albert Grip-enhancing glove
AU766599B2 (en) 1998-11-18 2003-10-16 Dabur Pharma Ltd. Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
WO2001007646A2 (de) 1999-07-21 2001-02-01 Martin Heinkelein Verfahren zur quantifizierung der antiviralen wirkung antiviraler wirkstoffe
BR9917495A (pt) 1999-09-09 2002-06-11 Dabur Res Foundation Derivados o ácido betulìnico tendo atividade antiangiogênica, processos para produzir tais derivados e sua utilização para o tratamento de antiogênese associada a tumores
US7488722B2 (en) 2001-05-11 2009-02-10 University Of Ottawa Anxiolytic Marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods
WO2003037908A1 (en) 2001-10-31 2003-05-08 Ribapharm Inc. Antiviral combination therapy and compositions
CA2515384C (en) 2003-02-11 2012-04-17 Novelix Pharmaceuticals, Inc. Medicament for inhibiting tumour growth
US7026305B2 (en) 2003-04-14 2006-04-11 Meharry Medical College Anti-HIV agents with dual sites of action
WO2005090380A1 (en) 2004-03-17 2005-09-29 Panacos Pharmaceuticals, Inc. Pharmaceuticals salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid
MX2007005129A (es) 2004-10-27 2007-09-11 Daiichi Sankyo Co Ltd Compuesto de benceno que tiene 2 o mas sustituyentes.
TW200628161A (en) 2004-11-12 2006-08-16 Panacos Pharmaceuticals Inc Novel betulin derivatives, preparation thereof and use thereof
EP1869063A2 (en) 2005-03-29 2007-12-26 Regents Of The University Of Minnesota Methods of manufacturing bioactive 3-esters of betulinic aldehyde and betulinic acid
CN101287744A (zh) 2005-06-22 2008-10-15 美瑞德生物工程公司 抗病毒化合物
EP1893629A4 (en) 2005-06-22 2008-12-17 Myriad Genetics Inc ANTIVIRAL CONNECTIONS
CN100475835C (zh) 2006-05-12 2009-04-08 中国药科大学 23-羟基白桦酸类衍生物、其制备方法、制剂及用途
FI121468B (fi) 2006-06-07 2010-11-30 Valtion Teknillinen Betuliiniperäiset yhdisteet antimikrobisina aineina
FI20065389A7 (fi) 2006-06-07 2007-12-31 Valtion Teknillinen Tutkimuskeskus Betuliiniperäiset yhdisteet kasvien tuholaisten syönnin estäjinä
WO2008127364A2 (en) 2006-10-13 2008-10-23 Myriad Genetics, Inc. Antiviral compounds and use thereof
US20090105203A1 (en) 2006-10-16 2009-04-23 Myriad Genetics, Incorporated Compounds for treating viral infections
WO2008057420A2 (en) * 2006-11-03 2008-05-15 Panacos Pharmaceuticals, Inc. Extended triterpene derivatives
US20110152229A1 (en) 2006-11-22 2011-06-23 Duke University Betulinic acid derivatives as anti-hiv agents
WO2008091532A1 (en) 2007-01-19 2008-07-31 Panacos Pharmaceuticals, Inc. Salts of 3-o-(3',3'-dimethylsuccinyl)betulinic acid and solid state forms thereof
CA2711420A1 (en) 2008-01-03 2009-07-09 Virochem Pharma Inc. Novel c-21-keto lupane derivatives preparation and use thereof
JP2011508748A (ja) * 2008-01-03 2011-03-17 バイロケム ファーマ インコーポレイテッド 新規のルパン誘導体
AU2009214779A1 (en) 2008-02-14 2009-08-20 Virochem Pharma Inc. Novel 17beta lupane derivatives
US8431556B2 (en) 2008-03-26 2013-04-30 Vertex Pharmaceuticals Incorporated C-21-keto lupane derivatives preparation and use thereof
US20120101098A1 (en) 2009-05-15 2012-04-26 Kuo-Hsiung Lee 3,28-disubstituted betulinic acid derivatives as anti-hiv agents
US8802727B2 (en) 2009-07-14 2014-08-12 Hetero Research Foundation, Hetero Drugs Limited Pharmaceutically acceptable salts of betulinic acid derivatives
US9067966B2 (en) 2009-07-14 2015-06-30 Hetero Research Foundation, Hetero Drugs Ltd. Lupeol-type triterpene derivatives as antivirals
CN102883608A (zh) 2010-02-11 2013-01-16 葛兰素史密丝克莱恩有限责任公司 白桦脂醇衍生物
WO2011153315A1 (en) 2010-06-04 2011-12-08 Bristol-Myers Squibb Company Modified c-3 betulinic acid derivatives as hiv maturation inhibitors
PT2576586E (pt) 2010-06-04 2015-10-23 Bristol Myers Squibb Co Amidas c-28 de derivados de ácido betulínico c-3 modificadas como inibidores de maturação de hiv
US20140221328A1 (en) 2011-01-10 2014-08-07 Bandi Parthasaradhi Reddy Pharmaceutically acceptable salts of novel betulinic acid derivatives
WO2013001144A1 (en) 2011-06-30 2013-01-03 Nokia Corporation Method and apparatus for face tracking utilizing integral gradient projections
WO2013020245A1 (en) 2011-08-08 2013-02-14 Glaxosmithkline Llc Carbonyl derivatives of betulin
WO2013090683A1 (en) 2011-12-14 2013-06-20 Glaxosmithkline Llc Propenoate derivatives of betulin
WO2013091144A1 (en) 2011-12-21 2013-06-27 Glaxosmithkline Llc Propenoate derivatives of betulin
JO3387B1 (ar) 2011-12-16 2019-03-13 Glaxosmithkline Llc مشتقات بيتولين
CN103242413B (zh) * 2012-02-08 2015-08-26 江西青峰药业有限公司 Lupane三萜系衍生物及其药学用途
US20150119373A1 (en) 2012-04-24 2015-04-30 Hetero Research Foundation Novel betulinic acid derivatives as hiv inhibitors
HK1209638A1 (en) 2012-12-14 2016-04-08 Glaxosmithkline Llc Pharmaceutical compositions
US9637516B2 (en) 2012-12-31 2017-05-02 Hetero Research Foundation Betulinic acid proline derivatives as HIV inhibitors
US20170129916A1 (en) 2014-06-26 2017-05-11 Hetero Research Foundation Novel betulinic proline imidazole derivatives as hiv inhibitors
WO2015198263A2 (en) 2014-06-26 2015-12-30 Hetero Research Foundation Novel betulinic proline substituted derivatives as hiv inhibitors
MA40886B1 (fr) 2015-02-09 2020-03-31 Hetero Research Foundation Nouveau triterpénone en c-3 avec des dérivés d'amide inverse en c-28 en tant qu'inhibiteurs du vih
US10370405B2 (en) 2015-03-16 2019-08-06 Hetero Labs Limited C-3 novel triterpenone with C-28 amide derivatives as HIV inhibitors
WO2017017630A1 (en) 2015-07-28 2017-02-02 Hetero Research Foundation Novel betulinic substituted amide derivatives as hiv inhibitors
WO2017021922A1 (en) 2015-08-05 2017-02-09 Hetero Research Foundation Novel substituted amides of triterpene derivatives as hiv inhibitors
US10669305B2 (en) 2015-10-13 2020-06-02 Hetero Labs Limited C-3 novel triterpenone with C-28 urea derivatives as HIV inhibitors
WO2017115329A1 (en) 2015-12-30 2017-07-06 Hetero Research Foundation C-3 novel triterpenone derivatives as hiv inhibitors
WO2017149518A1 (en) 2016-03-04 2017-09-08 Hetero Labs Limited C-3 novel triterpene with c-17 amine derivatives as hiv inhibitors
WO2018025247A1 (en) 2016-08-05 2018-02-08 Hetero Labs Limited C-3 novel triterpenone with c-28 diamide derivatives as hiv inhibitors
WO2018029604A1 (en) 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide derivatives as hiv inhibitors
WO2018029602A1 (en) 2016-08-08 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-28 heterocycle derivatives as hiv inhibitors
WO2018029610A1 (en) 2016-08-09 2018-02-15 Hetero Labs Limited C-3 novel triterpenone with c-17 n-amide derivatives as hiv inhibitors
US20180097839A1 (en) 2016-10-01 2018-04-05 Neeraj S. Upasani Systems, apparatuses, and methods for platform security
WO2018069857A1 (en) 2016-10-12 2018-04-19 Hetero Labs Limited C-3 novel triterpenone with c-17 reverse amide heterocycle derivatives as hiv inhibitors

Also Published As

Publication number Publication date
CU20170102A7 (es) 2018-01-10
US20170008921A1 (en) 2017-01-12
MA40886B1 (fr) 2020-03-31
ZA201705253B (en) 2020-01-29
EP3256483A2 (en) 2017-12-20
AU2016258274B2 (en) 2019-12-05
US20180215780A1 (en) 2018-08-02
CO2017008765A2 (es) 2017-11-10
PH12017550077A1 (en) 2018-02-12
MX2017010297A (es) 2018-11-12
KR20170110143A (ko) 2017-10-10
EP3256483B1 (en) 2019-12-11
IL253844A0 (en) 2017-09-28
ES2780649T3 (es) 2020-08-26
EA033264B1 (ru) 2019-09-30
US11034718B2 (en) 2021-06-15
US10533035B2 (en) 2020-01-14
CN107428797A (zh) 2017-12-01
DK3256483T3 (da) 2020-03-23
CU24476B1 (es) 2020-03-04
CA2975359A1 (en) 2016-11-10
WO2016178092A8 (en) 2017-09-21
JP2018505216A (ja) 2018-02-22
BR112017017109A2 (pt) 2018-04-03
PE20171433A1 (es) 2017-09-26
WO2016178092A3 (en) 2017-01-05
US20200087342A1 (en) 2020-03-19
SG11201706189PA (en) 2017-08-30
EA201791807A1 (ru) 2018-01-31
WO2016178092A2 (en) 2016-11-10
AU2016258274A1 (en) 2017-09-07

Similar Documents

Publication Publication Date Title
CL2017002034A1 (es) Nueva triterpenona c-3 con derivados de amida inversa c-17 como inhibidores de vih.
CL2019002204A1 (es) Compuestos inhibidores del vih.
CL2016000698A1 (es) Derivados de quinolizina sustituidos útiles como inhibidores de integrasa del vih
CL2018000684A1 (es) Moduladores de la proteína de núcleo de la hepatitis b.
CU24397B1 (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b
MX2017002028A (es) Compuestos de pirrolopirimidina usados como agonista del receptor de tipo toll 7 (tlr7).
CL2016001973A1 (es) Derivados de nucleosido sustituidos con 4&#39; -difluorometilo como inhibidores de la replicación de arn de la influenza.
MX2016011034A (es) Compuestos de amida para el tratamiento de trastornos mediados por complemento.
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
CL2015002445A1 (es) Compuestos amida para el tratamiento del vih
MX371050B (es) Compuestos para tratar atrofia muscular espinal.
CO2018000589A2 (es) Oxiesteroles y composiciones farmacéuticas que los contienen
MX376122B (es) Composiciones de plinabulina.
MX2019002438A (es) Compuestos triciclicos fusionados de piridazinona utiles para tratar infecciones de orthomyxovirus.
CR20170005A (es) Derivados de insoindolina
EA201591406A1 (ru) C-19 модифицированные тритерпеноиды с ингибиторной активностью созревания вич
CL2017000152A1 (es) Derivados de isoindolinona
MX2017011655A (es) Compuestos de aza-piridona y usos de estos.
MX384392B (es) Moduladores heterocíclicos de la síntesis de lípidos para su uso contra el cáncer e infecciones virales.
MX374383B (es) Derivados de carboxamida como inhibidores de smurf-1
MX2018005158A (es) Compuestos para el tratamiento de trastornos hipoproliferativos.
BR112017009289A2 (pt) métodos de administrar composições de amantadina
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
CL2017000151A1 (es) Derivados de piridona
MX376741B (es) Composición farmaceútica de sulfonamida